Insmed Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Insmed Inc
INSM Stock  USD 159.03  5.88  3.57%   
Insmed's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Insmed's valuation are provided below:
Gross Profit
483.5 M
Profit Margin
(2.11)
Market Capitalization
33.9 B
Enterprise Value Revenue
77.9111
Revenue
606.4 M
There are over one hundred nineteen available fundamental trends for Insmed Inc, which can be analyzed over time and compared to other ratios. Self-guided Investors are advised to confirm Insmed's regular fundamentals against the trend between 2010 and 2026 to make sure the company can sustain itself down the road. As of the 24th of February 2026, Market Cap is likely to grow to about 10.7 B. Also, Enterprise Value is likely to grow to about 11.4 B

Insmed Total Revenue

636.74 Million

Check Insmed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Insmed's main balance sheet or income statement drivers, such as Depreciation And Amortization of 17.3 M, Interest Expense of 88 M or Total Revenue of 636.7 M, as well as many indicators such as Price To Sales Ratio of 58.25, Dividend Yield of 0.0 or PTB Ratio of 52.83. Insmed financial statements analysis is a perfect complement when working with Insmed Valuation or Volatility modules.
  
Build AI portfolio with Insmed Stock
Check out the analysis of Insmed Correlation against competitors.

Insmed Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets2.4 B2.3 B870.8 M
Slightly volatile
Other Current Liabilities478.9 M456.1 M104.9 M
Slightly volatile
Total Current Liabilities492.3 M468.9 M132.1 M
Slightly volatile
Property Plant And Equipment Net146.2 M139.2 M57.6 M
Slightly volatile
Accounts Payable88.2 M84 M31.1 M
Slightly volatile
Cash258 M510.4 M371.6 M
Slightly volatile
Non Current Assets Total493.9 M470.4 M203.8 M
Slightly volatile
Non Currrent Assets Other102.2 M97.4 M33.8 M
Slightly volatile
Cash And Short Term Investments1.5 B1.4 B576.5 M
Slightly volatile
Common Stock Total Equity804.3 K1.6 M812.7 K
Slightly volatile
Common Stock Shares Outstanding224.3 M213.6 M91.3 M
Slightly volatile
Liabilities And Stockholders Equity2.4 B2.3 B870.8 M
Slightly volatile
Other Current Assets95.8 M91.2 M22.7 M
Slightly volatile
Other Stockholder Equity6.7 B6.4 B2.2 B
Slightly volatile
Total Liabilities1.6 B1.5 B627.9 M
Slightly volatile
Property Plant And Equipment Gross200.3 M190.8 M69.4 M
Slightly volatile
Total Current Assets1.9 B1.8 B667 M
Slightly volatile
Common Stock2.3 M2.1 M964.9 K
Slightly volatile
Other Liabilities73 M69.6 M26.8 M
Slightly volatile
Other Assets137.3 M130.7 M58.1 M
Slightly volatile
Good Will78.7 M156.5 M80.3 M
Slightly volatile
Non Current Liabilities Total1.1 B1.1 B495.9 M
Slightly volatile
Intangible Assets64 M97.7 M59.5 M
Slightly volatile
Property Plant Equipment68.2 M65 M31.6 M
Slightly volatile
Net Receivables147.9 M140.9 M30.3 M
Slightly volatile
Short Term Debt13.1 M12.8 M15.2 M
Very volatile
Short and Long Term Debt Total43.4 M45.7 M336.6 M
Slightly volatile
Long Term Debt1.3 B1.3 B456.3 M
Slightly volatile
Capital Surpluse3.4 B3.2 B1.7 B
Slightly volatile
Non Current Liabilities Other369.2 M351.6 M104.6 M
Slightly volatile
Long Term Debt Total1.4 B1.3 B460.4 M
Slightly volatile
Short and Long Term Debt38 M63.9 M42.9 M
Slightly volatile
Net Invested Capital903.9 M1.6 B705.4 M
Slightly volatile
Net Working Capital766 M1.5 B604.3 M
Slightly volatile
Capital Stock1.3 M2.1 M1.1 M
Slightly volatile
Capital Lease Obligations40.3 M40.9 M54.9 M
Slightly volatile

Insmed Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization17.3 M16.4 M7 M
Slightly volatile
Other Operating Expenses1.9 B1.8 B532.2 M
Slightly volatile
Research Development809.6 M771.1 M255.9 M
Slightly volatile
Total Operating Expenses1.7 B1.7 B498.5 M
Slightly volatile
Selling General Administrative736.2 M701.2 M210.7 M
Slightly volatile
Selling And Marketing Expenses12.1 M23.9 M19.3 M
Pretty Stable
Interest Income2.4 M2.6 M4.2 M
Very volatile
Reconciled Depreciation10.7 M12.7 M7.2 M
Slightly volatile

Insmed Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow582.8 M555 M362 M
Slightly volatile
Depreciation17.3 M16.4 M7 M
Slightly volatile
Other Non Cash Items265.5 M252.9 M57.2 M
Slightly volatile
Capital Expenditures34.2 M32.6 M11.8 M
Slightly volatile
End Period Cash Flow257.5 M510.4 M371.6 M
Slightly volatile
Stock Based Compensation160.3 M152.7 M44.4 M
Slightly volatile
Sale Purchase Of Stock181.5 M358.4 M184.9 M
Slightly volatile
Change To Netincome28.4 M53.2 M30.1 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio58.2561.31263.1 K
Slightly volatile
Days Sales Outstanding48.1484.7804118
Slightly volatile
Stock Based Compensation To Revenue0.360.25180.9334
Slightly volatile
Capex To Depreciation1.881.97941.8597
Pretty Stable
EV To Sales57.5260.54633.1 K
Slightly volatile
Inventory Turnover1.060.94550.7125
Very volatile
Days Of Inventory On Hand534386724
Slightly volatile
Sales General And Administrative To Revenue0.770.80585.1493
Pretty Stable
Research And Ddevelopement To Revenue1.211.271526.437
Slightly volatile
Capex To Revenue0.0510.05376.8748
Slightly volatile
Cash Per Share8.226.69386.1301
Pretty Stable
Income Quality0.620.73230.7855
Pretty Stable
Intangibles To Total Assets0.20.10320.1848
Slightly volatile
Current Ratio3.643.82667.0681
Slightly volatile
Receivables Turnover4.094.30524.6028
Slightly volatile
Capex Per Share0.210.15240.1305
Pretty Stable
Revenue Per Share2.982.83861.1066
Slightly volatile
Interest Debt Per Share0.580.60623.3548
Slightly volatile
Debt To Assets0.01920.02020.3185
Slightly volatile
Graham Number36.1540.6744.392
Slightly volatile
Operating Cycle298471763
Slightly volatile
Ebt Per Ebit1.131.08071.0467
Slightly volatile
Long Term Debt To Capitalization0.04050.04260.4021
Slightly volatile
Total Debt To Capitalization0.05530.05820.4043
Slightly volatile
Quick Ratio3.373.5456.8944
Slightly volatile
Net Income Per E B T0.791.0040.9773
Pretty Stable
Cash Ratio1.031.08875.0017
Slightly volatile
Days Of Inventory Outstanding534386724
Slightly volatile
Days Of Sales Outstanding48.1484.7804118
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.81.03481.0255
Slightly volatile
Fixed Asset Turnover4.144.35612.3578
Pretty Stable
Debt Ratio0.01920.02020.3185
Slightly volatile
Price Sales Ratio58.2561.31263.1 K
Slightly volatile
Asset Turnover0.160.26780.1061
Slightly volatile

Insmed Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap10.7 B10.2 B5.6 B
Slightly volatile

Insmed Fundamental Market Drivers

Insmed Upcoming Events

22nd of February 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
22nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Insmed Financial Statements

Insmed investors utilize fundamental indicators, such as revenue or net income, to predict how Insmed Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue-11.1 M-10.5 M
Total Revenue606.4 M636.7 M
Cost Of Revenue124.9 M131.1 M
Stock Based Compensation To Revenue 0.25  0.36 
Sales General And Administrative To Revenue 0.81  0.77 
Research And Ddevelopement To Revenue 1.27  1.21 
Capex To Revenue 0.05  0.05 
Revenue Per Share 2.84  2.98 
Ebit Per Revenue(1.94)(2.04)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Insmed Inc is a strong investment it is important to analyze Insmed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insmed's future performance. For an informed investment choice regarding Insmed Stock, refer to the following important reports:
How To Invest In Insmed
Details
Is Insmed Stock a good investment?
Details
What is Insmed's Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Insmed Correlation against competitors.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Will Biotechnology sector continue expanding? Could Insmed diversify its offerings? Factors like these will boost the valuation of Insmed. Market participants price Insmed higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Insmed data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(6.18)
Revenue Per Share
3.047
Quarterly Revenue Growth
1.526
Return On Assets
(0.29)
Return On Equity
(2.49)
Investors evaluate Insmed Inc using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Insmed's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Insmed's market price to deviate significantly from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Insmed's market price signifies the transaction level at which participants voluntarily complete trades.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY